Local Sleep in Idiopathic Hypersomnia
SL-HIP
Sleeping With Open Eyes: Local Sleep in Idiopathic Hypersomnia
1 other identifier
interventional
60
1 country
1
Brief Summary
Idiopathic hypersomnia (IH) is a rare and poorly studied disease characterized by excessive daytime sleepiness different from that of narcolepsy (sleep drunkness non-recuperative naps and nocturnal blackout). Local sleep is a recent concept, proposing a local regulation of the sleep-wake state, characterized by slow waves (SW) restricted to certain regions of a globally awake brain. The investigators are going to investigate whether local sleep could explain the sleepiness of these patients better than the global occurrence of sleep which are not very frequent during daytime tests in IH. The investigators propose to look for local sleep through the detection of local slow waves in the EEG of resting wakefulness and during an attentional task in people with IH compared to people with NT1 (sleepy, but with a different type of sleepiness from IH, more abrupt and including REM sleep) and non sleepy people.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 29, 2023
CompletedFirst Posted
Study publicly available on registry
December 1, 2023
CompletedStudy Start
First participant enrolled
December 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2024
CompletedDecember 1, 2023
November 1, 2023
Same day
September 29, 2023
November 29, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
local sleep topography
Density and topography of local sleep through the detection of local slow waves (SW) during resting wakefulness and during a daytime attentional test in IH, narcolepsy and healthy subjects
At enrollment visit
Secondary Outcomes (3)
Daytime dynamics of local sleep
At enrollment visit
behavioral implications of local sleep
At enrollment visit
correlation between local sleep and behavioral marker of alertness
At enrollment visit
Study Arms (3)
Idiopathic Hypersomnia
EXPERIMENTALNarcolepsy type 1
ACTIVE COMPARATORHealthy subject
ACTIVE COMPARATORInterventions
EEG recording while awake, at rest then during an attentional cognitive test
Sustained attention go-no-go task (press a button each time a number is presented on a screen (1/second) except when the 3 appears) Assessment of mental status approximately every 45 seconds (task focus, mind wandering, mental blank, and sleepiness status)
Study of pupil size and gaze path during the cognitive test (correlated with alertness)
Abdominal and thoracic belts (used in all nocturnal polysomnographic recordings) for respiratory movement studies (correlated with sleepiness)
Eligibility Criteria
You may qualify if:
- Healthy subjects and people with IH and NT1:
- \>18 years old, of both sexes, without legal protection.
- Affiliated to the French social security system
- Signature of free and informed consent
- Fluency in spoken and written French
- Specific to people with IH:
- Diagnosis of IH according to the ICSD-3, already made in the sleep pathology department of the Pitié after a specialized medical interview and a standardized 48h assessment (Night 1+TILE+Night 2+two naps): Sleep time \> 660 min or TILE latency \<8 min, \<2 SOREMPs.
- Specific to people with NT1:
- Diagnosis of narcolepsy type 1 according to the ICSD-3, already made in the sleep pathology department of the Pitié after a specialized medical interview and a standardized 48h workup (Night 1+TILE+Night 2+two naps) and sometimes a lumbar puncture: hypocretin \<110 pmol/L in CSF or cataplexy and TILE latency \<8 min, \>1 SOREMP.
You may not qualify if:
- Shift or night work
- Sleep debt on the day of the recording (questioning and sleep diary one week before the recording)
- Other sleep pathology causing daytime sleepiness (sleep apnea, insomnia, parasomnia for example)
- Cerebral neurological pathology
- Depressive episode
- Any psychotropic treatment modifying the EEG structure
- Failure to wean from arousing treatment on the day of the test.
- Inability to travel by transport or to be transported by a relative on the day of the recording.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pitié Salpêtrière
Paris, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Isabelle Arnulf, MD, PhD
Assistance Publique - Hôpitaux de Paris
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 29, 2023
First Posted
December 1, 2023
Study Start
December 1, 2023
Primary Completion
December 1, 2023
Study Completion
May 1, 2024
Last Updated
December 1, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share
The data will be confidential until their publication in a peer reviewed journal. Sharing will be feasible after, in case of reasonable request to the PI.